{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T01:03:45Z","timestamp":1794877425862,"version":"4.9.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:p>\n                    Three cases of superficial acral fibroblastic spindle cell neoplasms with\n                    <jats:italic toggle=\"yes\">EWSR1-SMAD3<\/jats:italic>\n                    fusion have been recently reported. Their differential diagnosis is broad, primarily comprising rare tumors from the fibroblastic\/myofibroblastic category. The aim of this report is to present 4 new cases of this entity and to discuss the appropriate differential diagnosis. Also, as the ERG antibody seems to be a characteristic marker for these tumors, we analyzed ERG immunostaining characteristics in potential mimics of this entity. All cases in our cohort occurred in women aged 5 to 68 years (mean, 36.5\u2009y). Two were located on the hand, 1 on foot, and the last case arose on the calf. The tumor size ranged from 1 to 1.5\u2009cm in the greatest dimension, with a mean size of 1.2\u2009cm. Except for one recent case, follow-up was available, ranging from 7 to 18 years (mean, 11.7\u2009y), with a recurrence noted in 1 case after 10 years. All tumors were subcutaneous and showed 2 main components. One consisted of bland, spindled cells with elongated nuclei which were round when observed on the cross-section. These cells mostly grew in relatively hypercellular, well-organized, and intersecting fascicles. The second component was prominently hyalinized and paucicellular, but lacked calcifications. Both components showed either a distinct zonation pattern, or they were randomly intermingled with each other. In all 3 analyzable tumors, next-generation sequencing showed\n                    <jats:italic toggle=\"yes\">EWSR1-SMAD3<\/jats:italic>\n                    gene fusion in each case. By fluorescence in situ hybridization, one tested case also revealed unbalanced rearrangement of the\n                    <jats:italic toggle=\"yes\">EWSR1<\/jats:italic>\n                    gene. All 4 cases showed strong, diffuse nuclear expression of ERG, whereas none of the mimics stained with this antibody except for weak to moderate staining in calcifying aponeurotic fibromas (9\/10 cases). Two tumors showed focal weak to moderate expression of SAT-B2. The 4 herein presented cases further broaden the clinicopathologic spectrum of tumors with\n                    <jats:italic toggle=\"yes\">EWSR1-SMAD3<\/jats:italic>\n                    gene fusion. They also confirm that they represent a novel entity for which we propose the name\n                    <jats:italic toggle=\"yes\">EWSR1-SMAD3<\/jats:italic>\n                    \u2013rearranged fibroblastic Tumor. Our study also proves that in the context of fibroblastic\/myofibroblastic tumors, ERG immunohistochemistry is a relatively specific marker for these neoplasms.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000001109","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T16:21:57Z","timestamp":1530116517000},"page":"1325-1333","source":"Crossref","is-referenced-by-count":57,"title":["EWSR1-SMAD3\u2013rearranged Fibroblastic Tumor"],"prefix":"10.1097","volume":"42","author":[{"given":"Michael","family":"Michal","sequence":"first","affiliation":[{"name":"Department of Pathology"},{"name":"Biomedical Center, Charles University Faculty of Medicine in Pilsen"},{"name":"Bioptical Laboratory Ltd, Pilsen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Berry","sequence":"additional","affiliation":[{"name":"Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P.","family":"Rubin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Kilpatrick","sequence":"additional","affiliation":[{"name":"Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Agaimy","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Friedrich-Alexander University Erlangen-N\u00fcrnberg, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry V.","family":"Kazakov","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"Bioptical Laboratory Ltd, Pilsen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Steiner","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"Bioptical Laboratory Ltd, Pilsen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Ptakova","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"Bioptical Laboratory Ltd, Pilsen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Martinek","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"Bioptical Laboratory Ltd, Pilsen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladislav","family":"Hadravsky","sequence":"additional","affiliation":[{"name":"Department of Pathology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kvetoslava","family":"Michalova","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"Bioptical Laboratory Ltd, Pilsen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Szep","sequence":"additional","affiliation":[{"name":"Cytopathos Ltd, Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Michal","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"Bioptical Laboratory Ltd, Pilsen"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/PAS.0000000000001002","article-title":"Novel EWSR1-SMAD3 gene fusions in a group of acral fibroblastic spindle cell neoplasms","volume":"42","author":"Kao","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PAS.0000000000000972","article-title":"Molecular profiling of mammary analog secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation: report of 10 cases","volume":"42","author":"Skalova","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/PAS.0b013e318206b67b","article-title":"ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma","volume":"35","author":"Miettinen","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/modpathol.2012.97","article-title":"Expression of ERG, an Ets family transcription factor, identifies ERG-rearranged Ewing sarcoma","volume":"25","author":"Wang","year":"2012","journal-title":"Mod Pathol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/pcan.2010.23","article-title":"ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification","volume":"13","author":"Furusato","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/jclinpath-2014-202601","article-title":"ERG expression in chondrogenic bone and soft tissue tumours","volume":"68","author":"Shon","year":"2015","journal-title":"J Clin Pathol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00795-015-0115-2","article-title":"ERG and FLI1 are useful immunohistochemical markers in phosphaturic mesenchymal tumors","volume":"49","author":"Tajima","year":"2016","journal-title":"Med Mol Morphol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/PAS.0000000000000752","article-title":"Recurrent somatic PDGFRB mutations in sporadic infantile\/solitary adult myofibromas but not in angioleiomyomas and myopericytomas","volume":"41","author":"Agaimy","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1097\/00000478-200011000-00004","article-title":"A clinicopathologic study of 45 pediatric soft tissue tumors with an admixture of adipose tissue and fibroblastic elements, and a proposal for classification as lipofibromatosis","volume":"24","author":"Fetsch","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0046-8177(98)90022-3","article-title":"Calcifying aponeurotic fibroma: a clinicopathologic study of 22 cases arising in uncommon sites","volume":"29","author":"Fetsch","year":"1998","journal-title":"Hum Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/path.4683","article-title":"FN1-EGF gene fusions are recurrent in calcifying aponeurotic fibroma","volume":"238","author":"Puls","year":"2016","journal-title":"J Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0000000000000675","article-title":"Recurrent NTRK1 gene fusions define a novel subset of locally aggressive lipofibromatosis-like neural tumors","volume":"40","author":"Agaram","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/path.4465","article-title":"Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour","volume":"235","author":"Lee","year":"2015","journal-title":"J Pathol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/modpathol.2016.137","article-title":"Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors","volume":"29","author":"Lee","year":"2016","journal-title":"Mod Pathol"},{"key":"R15-20230922","first-page":"18","article-title":"Lipofibromatosis (LPF): a clinicopathological and molecular genetic study of 16 cases suggesting a link to calcifying aponeurotic fibroma (CAF) and LPF-like neural tumor (LPFLNT)","volume":"31","author":"Al-Ibraheemi","year":"2018","journal-title":"Mod Pathol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/PAS.0000000000000270","article-title":"Myofibromas with atypical features: expanding the morphologic spectrum of a benign entity","volume":"38","author":"Linos","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/PAS.0000000000000811","article-title":"Recurrent SRF-RELA fusions define a novel subset of cellular myofibroma\/myopericytoma: a potential diagnostic pitfall with sarcomas with myogenic differentiation","volume":"41","author":"Antonescu","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0b013e3181788533","article-title":"Infantile digital fibroma\/fibromatosis: a clinicopathologic and immunohistochemical study of 69 tumors from 57 patients with long-term follow-up","volume":"33","author":"Laskin","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/00000478-200606000-00007","article-title":"Minute synovial sarcomas of the hands and feet: a clinicopathologic study of 21 tumors less than 1\u2009cm","volume":"30","author":"Michal","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/PAS.0b013e3182772bba","article-title":"Cutaneous syncytial myoepithelioma: clinicopathologic characterization in a series of 38 cases","volume":"37","author":"Jo","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/modpathol.2011.108","article-title":"EWSR1 gene rearrangement occurs in a subset of cutaneous myoepithelial tumors: a study of 18 cases","volume":"24","author":"Flucke","year":"2011","journal-title":"Mod Pathol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/PAS.0b013e3181c7d8b2","article-title":"Cutaneous clear cell sarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 12 cases emphasizing its distinction from dermal melanoma","volume":"34","author":"Hantschke","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/path.4701","article-title":"Paediatric and adult soft tissue sarcomas with NTRK1 gene fusions: a subset of spindle cell sarcomas unified by a prominent myopericytic\/haemangiopericytic pattern","volume":"238","author":"Haller","year":"2016","journal-title":"J Pathol"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/PAS.0000000000000938","article-title":"Recurrent BRAF gene fusions in a subset of pediatric spindle cell sarcomas: expanding the genetic spectrum of tumors with overlapping features with infantile fibrosarcoma","volume":"42","author":"Kao","year":"2018","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201810000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T18:29:22Z","timestamp":1695407362000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201810000-00006"}},"subtitle":["An Emerging Entity in an Increasingly More Complex Group of Fibroblastic\/Myofibroblastic Neoplasms"],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001109","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733529328.793554203","asserted-by":"object"}]},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}